BDBM316958 N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyrimidine- 5-carbonyl)-phenyl]-4- isopropyl- benzenesulfonamide::US9617267, Compound P-1009
SMILES: CC(C)c1ccc(cc1)S(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncnc(C)c23)c1F
InChI Key: InChIKey=SBOWWRAEFKKHTA-UHFFFAOYSA-N
Data: 9 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase B-raf (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >100 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Assays for biochemical and cell based activity are known in the art, for example, as described in PCT publication WO 2007/002433, the disclosure of w... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor(L858R, T790M) (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB KEGG B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >100 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Assays for biochemical and cell based activity are known in the art, for example, as described in PCT publication WO 2007/002433, the disclosure of w... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Assays for biochemical and cell based activity are known in the art, for example, as described in PCT publication WO 2007/002433, the disclosure of w... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, whe... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 3A4 (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, whe... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2C9 (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, whe... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, whe... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 3A4 (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, whe... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2C19 (Homo sapiens (Human)) | BDBM316958 (N-[2,4-Difluoro-3-(4-methyl- 7H-pyrrolo[2,3-d]pyri...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description The inhibition of CYP enzyme activity (IC50) for each of CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4(BFC) and CYP3A4(BQ) is determined for compounds, whe... | US Patent US9617267 (2017) BindingDB Entry DOI: 10.7270/Q2WM1GHS | |||||||||||
More data for this Ligand-Target Pair |